Christa Pike conscious and speaking days after botched execution.

Tennessee failed to execute Christa Pike on Oct. 1, 2026, after two doses of pentobarbital did not kill her over roughly two hours. She was rushed to a hospital and remains critically ill.

• At least 7 needles were used before IV lines were established, Pike's lawyers said.
• Pike's arms were swollen, burned, and blistered; one arm turned purple, attorneys said.
• 2 previous Tennessee executions in the prior 14 months also encountered serious problems.
• Gary Wayne Sutton's Dec. 3 execution date is now canceled pending the state review.

Why it matters: Legal experts say this is the first known U.S. case of a prisoner surviving one full dose — let alone two — of lethal injection drugs.

• Pike's lawyers had warned courts months earlier that her small veins and a blood disorder made a painful, complicated procedure likely.
• The American Medical Association and American Nurses Association bar members from participating in executions, leaving states to use non-medical personnel.

How 56 sources split on this story

Where they split: Observers disagree on who bears primary responsibility: the state's execution team and secrecy around drugs and training, or death-penalty opponents whose campaigns restrict medical participation and drug access.

What’s next: Gov. Lee ordered a comprehensive third-party review and paused all 2026 executions.

• Pike's attorneys filed a motion demanding the state preserve all evidence from the attempt.
• Tennessee Department of Correction's director resigned days after the failed procedure.
• Why exactly did two full doses of pentobarbital fail to kill Pike — drug degradation, improper IV placement, or another cause?
• Will Tennessee attempt to execute Pike again once the review concludes, and what legal challenges would follow?
• Will other states with scheduled executions change their protocols in response to Tennessee's experience?